PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1463771
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1463771
Key Highlights
The medical packaging films market generated a value of USD 7,904.2 million in 2023, which will increase to USD 11,752.8 million, powering at more than 6.0% compound annual growth rate, by 2030.
The patient populace across different regions has been rising, because of the increase in the prevalence of chronic ailments such as cancer, diabetes, and various other chronic disorders.
In response to these ailments, the requirement for medical services and products is rapidly rising, which, in turn, boosts the need for medical packaging films.
In 2022, over 1 million new cases of cancer were diagnosed in the U.S. Moreover, the incidence of rheumatoid arthritis, cardiovascular disorders (CVD), and various others is on the rise, because of the surging elderly population.
Bioplastics have observed a dynamic shift as well as demonstrated a significant increase in demand, because of the commercial acceptance, investments, research & development, and manufacturing, in the plastics industry.
Being produced from renewable feedstocks like corn, cellulose, and sugarcane, bioplastics are progressively becoming popular around the world, because of their extensive applications across different sectors including packaging, automotive, textiles, and consumer goods.
Thus, with their environmentally friendly properties, availability of renewable stocks, and auspicious government guidelines for developing sustainable solutions, the utilization of bioplastics is increasing.
Key Insights
APAC is likely to propel at the highest compound annual growth rate in the years to come.
In APAC, the rising healthcare spending along with increasing disposable salaries, the growing middle-class populace, and the accessibility of advanced pharmaceutical and medical solutions in the emerging economies are boosting the industry.
Thermoformable films were the largest contributor to the industry in 2023.
Thermoformable films are considered as a suitable packaging material for pharmaceutical consumables as well as non-consumables, because of the advantages related to it like soft, swift transformation time, low cost, and great-puncture resistance.
Thermoformable is a financially efficient, recyclable choice and guarantees product sustainability and protection. Also, it generates a sterilized barrier for single-use medical equipment that comes in various sizes and shapes.
The pharmaceutical category was the largest contributor to the medical packaging film industry in 2023, with a 45% share.
The more the utilization of pharmaceutical goods, the more the requirement for medical packaging solutions and materials, which, in turn, boosts the expansion of this category.
The polyethylene category accounted for a considerable share of the industry in 2023, of approximately 35%.
The polyethylene category is also likely to advance at a remarkable compound annual growth rate during this decade. This will be mainly because of its exceptional chemical resistance as well as great flexibility.
Polyethylene acts as a leak-proof barrier against moisture to prevent product contamination and further defends medical products against moisture, tampering, and germs, because of its enhanced sterilization.
Staying ahead in this competitive landscape necessitates constant innovation, strategic partnerships across the medical device & packaging value chain, and a robust emphasis on sustainability.
Mergers & acquisitions are also expected to play an important part as businesses try to increase their product portfolios as well as geographical reach.